Lexicon Pharmaceuticals Inc (LXRX) — Capital Reinvestment Ratio
Lexicon Pharmaceuticals Inc (LXRX) has a Capital Reinvestment Ratio of 0.00x as of September 2019, meaning it reinvests 0% of its operating cash flow ($190.70 Million) in capital expenditures ($70.00K). Check Lexicon Pharmaceuticals Inc tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Lexicon Pharmaceuticals Inc Capital Reinvestment Ratio (2005–2019)
This chart tracks Lexicon Pharmaceuticals Inc's Capital Reinvestment Ratio across 3 annual periods. For the full cash flow conversion analysis, see how efficiently does Lexicon Pharmaceuticals Inc generate cash.
Annual Capital Reinvestment Ratio for Lexicon Pharmaceuticals Inc (2005–2019)
Year-by-year Capital Reinvestment Ratio for Lexicon Pharmaceuticals Inc from 2005 to 2019. See free cash flow generation of Lexicon Pharmaceuticals Inc to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2019 | 0.00x | $113.81 Million | $70.00K | ▼ -87.5% |
| 2015 | 0.00x | $184.78 Million | $910.00K | ▼ -99.0% |
| 2005 | 0.48x | $23.44 Million | $11.28 Million | — |